Ecolab
ECL
$292.30
+1.46%
Ecolab is the global leader in water, hygiene, and infection-prevention products and services, serving industrial manufacturing, data centers, hospitality, healthcare, and life sciences customers through a portfolio spanning dish and laundry systems, pest elimination, infection control, and customized water management and cooling solutions. Its competitive identity rests on a service-intensive, razor-to-blade model embedded directly in customer operations, which produces sticky recurring revenue and pricing power that few specialty chemical peers can replicate. The current investor narrative centers on the company's $4.75 billion acquisition of CoolIT, a bold pivot into high-growth AI data-center liquid cooling that has been met with skepticism over purchase price and integration timing, even as organic growth accelerates. That debate is layered atop a broader question of whether Ecolab can sustain its recent double-digit top-line momentum and margin expansion while digesting a large, strategically adjacent deal.…
ECL
Ecolab
$292.30
ECL 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Ecolab's 12-month outlook, with a consensus price target around $325.05 and implied upside of +11.2% versus the current price.
Average Target
$325.05
0 analysts
Implied Upside
+11.2%
vs. current price
Analyst Count
—
covering this stock
Price Range
$295 - $360
Analyst target range
Coverage is broad and constructive, with 21 analysts following Ecolab and a consensus recommendation of Buy (mean rating 1.54 on a 1-to-5 scale). The average target price of $325.05 implies roughly 12.5% upside from the current $288.89, and notably even the lowest target of $295.00 sits above the current price — a rare configuration that signals near-universal conviction that the stock is undervalued at present levels. The consensus leans clearly bullish, supported by a steady stream of reaffirmations and one upgrade: Oppenheimer moved to Outperform from Perform on July 17, 2026, while BMO, JPMorgan, Mizuho, Deutsche Bank, RBC, and Citigroup all maintained Outperform or Buy ratings through the summer. The target range of $295.00 to $360.00 is moderately wide, with the $360 high implying about 25% upside and likely assuming successful CoolIT integration, accelerating data-center cooling revenue, and continued margin expansion toward the high end of historical ranges. The $295 low, just 2% above the current price, effectively prices in a scenario of modest multiple compression or slower organic growth with limited deal synergy. The clustering of targets above the current price and the absence of recent downgrades suggest strong institutional conviction, though the stock's 8.78-point one-year relative underperformance versus SPY indicates the market has yet to fully validate the analysts' optimism.
Bulls vs Bears: ECL Investment Factors
The bull case currently holds the stronger evidence: revenue growth has accelerated to 9.69% YoY, gross margins are stable in the 43.5%-44.8% band, free cash flow of $1.875 billion comfortably funds the dividend, and every one of 21 analyst targets sits above the current price with a $325.05 average implying 12.5% upside. The bear case rests less on fundamentals than on price: 35.8x trailing earnings near the top of the historical band, 7.61x book, and an unproven $4.75 billion CoolIT acquisition that the market greeted with a sell-off. The single most important tension is whether CoolIT becomes a credible AI-cooling growth engine that justifies the premium multiple, or whether integration costs and purchase-price skepticism drag the stock back toward its 24.6x historical PE floor. Resolving that question — most likely through data-center cooling revenue disclosure and margin trajectory over the next two to three quarters — would move the thesis more than any other factor.
Bullish
- Analyst floor sits above current price: All 21 covering analysts have targets above the $288.89 current price, with a $295.00 low and a $325.05 average implying 12.5% upside. The absence of any target below the market price is a rare configuration that signals near-universal conviction the stock is undervalued today.
- Revenue growth accelerating to 9.69% YoY: Q2 2026 revenue of $4.415 billion rose 9.69% from $4.025 billion a year ago, building on sequential gains from $4.066 billion in Q1 2026 and $4.196 billion in Q4 2025. This is a genuine multi-quarter acceleration, not a one-off comparison, and it is broad-based across Water Services ($2.223 billion) and Global Institutional ($1.621 billion).
- Margin discipline with stable gross margin: Gross margin has held in a tight 43.5% to 44.8% band over six quarters, with Q2 2026 at 44.07% and operating margin at 17.16%, up from 15.30% in Q1 2026. That stability demonstrates pricing power offsetting input costs, while trailing ROE of 21.24% and ROA of 7.23% confirm a capital-efficient franchise.
- Momentum inflection versus the market: ECL has outperformed SPY by 4.18 points over one month and 3.20 points over three months, a sharp reversal from its -8.78 point one-year relative underperformance. Combined with a 5.40% one-month gain versus the 6.75% one-year gain, recent performance is doing the heavy lifting and suggests a trend inflection rather than a bounce.
Bearish
- Premium multiple leaves no error margin: At 35.8x trailing and 30.7x forward earnings, 4.62x sales, 24.0x EV/EBITDA and 7.61x book, Ecolab trades well above commodity-leaning specialty chemical peers. The trailing PE sits near the upper end of its multi-year 24.6x to 44.6x band, so any CoolIT integration stumble or organic slowdown invites multiple compression toward the mid-range.
- CoolIT deal skepticism and execution risk: The $4.75 billion CoolIT acquisition is a large, strategically adjacent bet on AI data-center liquid cooling, and the stock's immediate decline on announcement showed investor skepticism over price and timing. Q2 2026 showed a $4.728 billion debt repayment alongside a $5.135 billion cash build, evidence of active balance-sheet maneuvering around a deal that has yet to prove synergies.
- Operating margin below year-ago level: Q2 2026 operating margin of 17.16% is below the 17.64% recorded in the year-ago Q2, and net margin of 12.11% trails the 13.02% from Q2 2025. Despite revenue growth of 9.69%, earnings conversion has not kept pace, which matters when the valuation already discounts roughly 16% forward EPS growth to $10.71.
- One-year relative underperformance persists: ECL has lagged SPY by 8.78 points over twelve months and by 2.35 points over six months, with a -20.31% maximum drawdown over the trailing period. The recent one- and three-month outperformance has not yet reversed the longer-term trend, meaning the market has not fully validated the analysts' optimism.
ECL Technical Analysis
Ecolab is in a sustained, orderly uptrend, with the stock up 6.75% over the past year and 9.99% year-to-date, and at $288.89 it trades at roughly 69% of its 52-week range of $243.15 to $309.27 — closer to the highs than the midpoint, signaling persistent accumulation rather than overextension. The stock has recovered decisively from its 52-week low, though the -20.31% maximum drawdown over the trailing period confirms it has absorbed meaningful volatility along the way. Short-term momentum is clearly accelerating: the stock is up 5.40% over the past month and 5.89% over three months, both well ahead of the 6.75% one-year gain, meaning recent performance is doing the heavy lifting. That acceleration is corroborated by relative strength, with ECL outperforming SPY by 4.18 percentage points over one month and 3.20 points over three months, a sharp reversal from its -8.78 point one-year relative underperformance — a divergence that suggests a genuine trend inflection rather than a temporary bounce. Key resistance sits at the 52-week high of $309.27, roughly 7% above the current price; a clean breakout would confirm the multi-month base and likely invite momentum buyers, while support rests at the $243.15 low, about 16% below. With a beta of just 0.879, Ecolab is roughly 12% less volatile than the market, which supports larger position sizing for risk-budgeted portfolios but also implies the stock will lag in sharp risk-on rallies; the 4.42 short ratio and 3.4 million average volume suggest no crowding on either side.
Beta
0.88
0.88x market volatility
Max Drawdown
-20.3%
Largest decline past year
52-Week Range
$243-$309
Price range past year
Annual Return
+5.9%
Cumulative gain past year
| Period | ECL Return | S&P 500 |
|---|---|---|
| 1m | +5.8% | -1.2% |
| 3m | +8.8% | +3.4% |
| 6m | +8.5% | +7.0% |
| 1y | +5.9% | +14.4% |
| ytd | +11.3% | +12.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ECL Fundamental Analysis
Revenue is growing at a healthy clip: Q2 2026 revenue of $4.415 billion rose 9.69% year-over-year from $4.025 billion, building on sequential gains from $4.066 billion in Q1 2026 and $4.196 billion in Q4 2025, confirming an accelerating multi-quarter trajectory. The Water Services segment at $2.223 billion and Global Institutional at $1.621 billion are the twin growth engines, together comprising the bulk of the business, while Global Pest Elimination at $351.1 million and Global Healthcare and Life Sciences at $221.0 million are smaller but higher-margin contributors. This breadth of growth across segments, rather than reliance on a single end market, strengthens the durability of the investment case and supports the strategic logic of the CoolIT data-center cooling expansion. Profitability is robust and improving: Q2 2026 net income reached $534.9 million on a 12.11% net margin, with gross margin of 44.07% and operating margin of 17.16%, up from a 15.30% operating margin in Q1 2026 and 17.64% in the year-ago Q2. Gross margin has been remarkably stable in the 43.5% to 44.8% band over the past six quarters, indicating pricing discipline is offsetting input cost pressure, while the trailing ROE of 21.24% and ROA of 7.23% reflect a high-quality, capital-efficient franchise. Balance sheet leverage is moderate at a debt-to-equity ratio of 0.965 and a current ratio of 1.076, with interest coverage of roughly 10.4x providing ample cushion. Free cash flow of $1.875 billion on a trailing basis and $489.4 million in Q2 2026 comfortably funds the $208.2 million quarterly dividend (payout ratio 36.3%) and buybacks, though the Q2 debt repayment of $4.728 billion alongside a $5.135 billion cash build signals active balance-sheet management around the CoolIT transaction; the 1.01% dividend yield and 25.2x price-to-cash-flow multiple reflect a premium cash-generative compounder rather than a yield play.
Quarterly Revenue
$4.4B
2026-06
Revenue YoY Growth
+9.7%
YoY Comparison
Gross Margin
44.1%
Latest Quarter
Free Cash Flow
$1.9B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ECL Overvalued?
Because Ecolab is solidly profitable — Q2 2026 net income of $534.9 million and trailing EPS positive — the PE ratio is the appropriate primary metric, and the trailing PE of 35.8x against a forward PE of 30.7x implies the market expects roughly 16% earnings growth over the next twelve months, consistent with consensus EPS of $10.71 versus the current run-rate. The gap between trailing and forward multiples is meaningful but not extreme, suggesting the market is pricing in steady rather than explosive earnings acceleration. On a peer basis, Ecolab trades at a premium to the specialty chemicals industry, with a PS ratio of 4.62x, EV/Sales of 5.36x, and EV/EBITDA of 24.0x — multiples that sit well above typical commodity-leaning chemical peers and reflect its service-based, recurring-revenue model. The premium is justified by superior profitability (44.5% gross margin, 18.1% operating margin, 21.2% ROE) and the defensive, mission-critical nature of its offerings, though the 7.61x price-to-book ratio leaves little room for execution missteps. Against its own history, the current 35.8x trailing PE sits near the upper end of its multi-year band, which has ranged from roughly 24.6x in Q3 2024 to 44.6x in Q1 2025, and the PS ratio of 4.62x is elevated relative to historical levels in the 11x to 19x range reported on a different share-count basis. This positioning indicates the market is pricing in optimistic expectations around AI cooling growth and margin expansion; a failure to deliver would leave the stock vulnerable to multiple compression toward its historical mid-range.
PE
35.8x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 25x~56x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
24.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on the balance sheet and earnings conversion. Debt-to-equity of 0.965 and a current ratio of just 1.076 leave limited liquidity headroom, and Q2 2026 showed a $4.728 billion debt repayment alongside a $5.135 billion cash build as the company actively manages the CoolIT transaction. Interest expense of $73.1 million per quarter is covered roughly 10.4x, which is adequate but would tighten if leverage rises further. More importantly, Q2 2026 operating margin of 17.16% is below the 17.64% year-ago level and net margin of 12.11% trails 13.02%, so 9.69% revenue growth is not yet converting into proportional earnings growth — a problem when the forward PE of 30.7x already discounts roughly 16% EPS growth to $10.71.
Market and competitive risks are dominated by valuation compression. At 35.8x trailing earnings, 4.62x sales, 24.0x EV/EBITDA and 7.61x book, Ecolab trades at a premium to specialty chemical peers that is justified only by its recurring-revenue service model and 44.5% gross margin. The trailing PE sits near the upper end of its 24.6x to 44.6x multi-year band, so a reversion to the mid-range would be painful even with stable fundamentals. The CoolIT acquisition adds competitive and integration risk in AI data-center cooling, a market with well-funded entrants, and the stock's immediate decline on the March 2026 announcement showed investors question the price and timing. A beta of 0.879 offers some macro insulation, but the 8.78-point one-year relative underperformance versus SPY shows the market has been rotating away from this profile.
The worst-case scenario is a CoolIT integration stumble combined with decelerating organic growth and multiple compression. If data-center cooling revenue disappoints, synergies slip, and the PE reverts toward its historical mid-range, the stock could retrace to the 52-week low of $243.15 — roughly 16% below the current $288.89. A more severe outcome, where the market applies a mid-band multiple to flat earnings, could push toward the -20.31% maximum drawdown already experienced over the trailing period, implying a loss of roughly 20% from current levels. Even the analyst low target of $295.00 sits above today's price, so the downside is not consensus-expected, but the 7.61x book multiple means the floor is valuation-driven rather than asset-supported.

